Statin [orch, phsu]
treatment [ftcn]
Heart failure [dsyn]
Controlled [ftcn]
rosuvastatin [orch, phsu]
Study [mnob]
Heart failure [dsyn]
Corona [euka]
Study Design [resa]
baseline [bodm]
Characteristics [qlco]
Previous [tmco]
Prospective Studies [resa]
Statins [orch, phsu]
Provided [acty]
Guidance [hlca]
benefit risk [qlco]
Patients [podg]
Heart failure [dsyn]
Primary [qlco]
Objective [inpr]
rosuvastatin [orch, phsu]
mg% [qnco]
Combined [qlco]
End Point [qlco]
CARDIOVASCULAR [bdsy]
Mortality [qnco]
Fatal [qlco]
Myocardial Infarction [dsyn]
Fatal [qlco]
Stroke [dsyn]
Event [evnt]
secondary [neop]
End Point [qlco]
Mortality [qnco]
Methods [inpr]
Corona [euka]
randomized controlled trial [inpr, resa]
DOUBLE BLIND [resa]
placebo [topp]
Men [popg]
Women [popg]
Aged [orga]
Chronic systolic heart failure [dsyn]
Symptomatic [ftcn]
Ischaemic [ftcn]
aetiology [ftcn]
ejection fraction [diap]
NYHA Class III [fndg]
NYHA Class II [fndg]
eligible [idcn]
Need [qlco]
cholesterol lowering drugs [phsu]
Age [orga]
N NOS [aapp, imft]
Women [popg]
Ii [aapp]
III [inpr]
ejection fraction [diap]
Total Cholesterol [lbpr]
mmol/L [qnco]
Percent [qnco]
History [ocdi]
Myocardial Infarction [dsyn]
Hypertension [dsyn]
Diabetes [dsyn]
Patients [podg]
Well [qlco]
treated [topp]
Heart failure [dsyn]
>90 [qnco]
Loop [medd]
Thiazide Diuretics [orch, phsu]
Aldosterone Antagonists [phsu]
ACE inhibitor [phsu]
AT-1 [gngm]
Beta-Blockers [phsu]
Digitalis [plnt]
Corona [euka]
Main [qlco]
reasons [idcn]
Very [qlco]
High Risk [qlco]
Study [mnob]
Increasing [ftcn]
Elderly [popg]
Patients [podg]
Chronic systolic heart failure [dsyn]
Symptomatic [ftcn]
society [orgt]
Health [idcn]
Economic [ocdi]
Issue [fndg]
Negative [qlco]
Mechanism [ftcn]
Question [inpr]
Heart failure [dsyn]
Raised [qnco]
Neutral [qlco]
Call [menp]
Polypharmacy [fndg]
European [popg]
society [orgt]
Cardiology [bmod]
Published [ocac]
Reserve [acty]
